[1] WORLD HEALTH ORGANIZATION.Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection[M].Geneva: World Health Organization, 2022. [2] COPPOLA N, ALESSIO L, ONORAT O, et al.Epidemiology and Management of Hepatitis C Virus Infections in Immigrant Populations[J].Infect Dis Poverty, 2019, 8(1):17. [3] WARKAD SD, SONG KS, PAL D, et al.Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies[J].Sensors(Basel), 2019, 19(19):4257. [4] WESTBROOK RH AND DUSHEIKO G.Natural history of hepatis C[J].J Hepatol, 2014, 61(Suppl 1):58-68. [5] TOWNSHEND-BULSON L, ROIK E, BARBOUR Y, et al.The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals[J].PLoS One, 2021, 16(12): e0260970. [6] 中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019版)[J].临床肝胆病杂志, 2019, 35(12): 2670-2686. [7] 丁国伟, 庞琳, 王晓春, 等. 2017-2019年哨点医院丙型肝炎基线特征及治疗现况分析[J].中华肝脏病杂志, 2020, 28(10): 844-849. [8] WORLD HEALTH ORGANIZATION. Global health sector strategy on viral hepatitis2016-2021[R].Geneva:World Health Organization. [9] 陈雨欣, 吴超. 医院内丙型肝炎筛查和转诊路径的建立与实施[J].中华肝脏病杂志, 2020, 28(10): 820-823. [10] 王飞, 卢岩, 张成普. 丙肝筛查与管理信息化平台的建设与应用研究[J].现代医院管理, 2018, 16(1): 79-80,86. [11] 黄睿, 饶慧瑛.“消除”背景下的丙型肝炎病毒感染现状及筛查、诊断对策[J].诊断学理论与实践, 2024, 23(1): 1-8. [12] 陆彦盟, 李仕雄, 向文耀, 等. 医院丙肝微消除模式的建立与应用成效[J].现代医院, 2024, 24(4): 651-653. [13] 中联肝健康促进中心, 中华医学会肝病学分会, 中华医学会检验医学分会, 等. 中国丙型病毒性肝炎院内筛查管理流程(试行)[J].中华肝脏病杂志, 2021, 29(4): 319-325. [14] 戚艳波, 贾豫晨. 2019年云南省法定传染病漏报与报卡质量分析[J].现代预防医学, 2021, 48(8):1511-1514. [15] GHANY MG,MORGAN TR, AASLD-IDSA HEPATITIS C GUIDANCE PANEL. Hepatitis C guidance 2019 update: American As sociation for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for testing,managing,and treating hepatitis C virus infection[J].Hepatology, 2020, 71(2): 686-721. [16] 陈海新. 细节管理和风险管理在血站质量管理体系中的应用分析[J].当代医学, 2020, 26(1): 114-116. [17] CHILLIE S, WESTER C, OSBORNE M, et al.CDC recommen-dations for hepatitis C screening among adults: United States, 2020[J].MMWR Recomm Rep, 2020, 69(2): 1-17. [18] 常宇琨, 章志丹.《丙型肝炎防治指南(2022版)》更新解读[J/CD].新发传染病电子杂志, 2023, 8(6): 89-92. [19] 李娜娜,张永栋. 丙型肝炎病毒基因分型的相关研究进展[J].临床医学进展, 2023, 13(5): 7598-7603. [20] 王焱, 韩军, 杨美蓉. 三种DAAs方案治疗慢性丙型肝炎患者两年随访研究[J].实用肝脏病杂志, 2024, 27(1): 32-35. |